Company

Grannus Therapeutics

Biotechnology Indianapolis, Indiana, United States 3 employees

Employees: 3
Contacts: 2
Emails: 2
Phones: 1

LinkedIn Crunchbase

Grannus Therapeutics Overview

Headquarters: Indianapolis, Indiana, United States
Industry: Biotechnology
Employees: 3
Founded: 2019
Funding: 800.0K

About Grannus Therapeutics

Founded in 2019, Grannus Therapeutics is a pre-clinical stage biotechnology company, focused on the development of small molecule inhibitors for specific isoforms of HSP90. Our lead program is focused on the development of a highly selective small molecule inhibitor of HSP90𝛽 for the treatment of multiple types of cancer. With this program, we have successfully engineered a molecule that selectively inhibits HSP90𝛽, potentially delivering the efficacy benefits of previous pan-inhibitors without their toxicity and dosing challenges.

Grannus Therapeutics Contact Details

People in AeroLeads: 3
With contact data: 2
Email contacts: 2; 66.7% coverage
Phone contacts: 1; 33.3% coverage

Grannus Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Ari Landon, Phd, Mba	VP of Life Sciences - Mba, Phd	United States	View
John Foglesong		Indianapolis, Indiana, United States	Email Phone
Sanket Mishra	Co-founder Grannus Therapeutics	Mishawaka, Indiana, United States	Email